Serum levels of VCAM-1 are associated with survival in patients treated with nivolumab for NSCLC.
Carbone F, Ministrini S, Bonaventura A, Vecchié A, Minetti S, Bardi N, Elia E, Ansaldo AM, Ferrara D, Rijavec E, Dal Bello MG, Biello F, Rossi G, Tagliamento M, Alama A, Coco S, Spallarossa P, Grossi F, Genova C, Montecucco F.
Carbone F, et al. Among authors: ansaldo am.
Eur J Clin Invest. 2022 Jan;52(1):e13668. doi: 10.1111/eci.13668. Epub 2021 Aug 22.
Eur J Clin Invest. 2022.
PMID: 34390488
Free PMC article.